Oryzon Genomics S.A. (FRA:ORN)
3.120
-0.150 (-4.59%)
At close: Jan 6, 2026
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of €250.75 million as of January 9, 2026. Its market cap has increased by 176.78% in one year.
Market Cap
250.75M
Enterprise Value
237.76M
Revenue
7.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.12
Market Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 122.00M to 250.75M, an increase of 105.54%. That is a compound annual growth rate of 7.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 250.75M | 2.25% |
| Dec 31, 2025 | 245.23M | 170.69% |
| Dec 31, 2024 | 90.60M | -16.71% |
| Dec 29, 2023 | 108.78M | -18.27% |
| Dec 30, 2022 | 133.08M | -6.58% |
| Dec 30, 2021 | 142.46M | -32.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |